Pharmather is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals. The company was founded with a particular focus on repurposing psychedelic pharmaceuticals, such as ketamine and psilocybin, for FDA approval to treat disorders of the brain and nervous system. Pharmather’s goal is to advance the development of panaceAI™, their drug repurposing artificial intelligence platform, and advance their clinical product pipeline with ketamine and psilocybin in Parkinson’s disease, depression, traumatic brain injury and stroke.